CHA Medical & Bio Group

Seongnam, KR
Find alternatives to CHA Medical & Bio Group for Cell Therapy →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
56.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: CHA Medical & Bio Group

Signal Score
56.5/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Seongnam, KR
Modalities
Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About CHA Medical & Bio Group

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 53.0
1 manufacturing site: Seongnam, KR
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Seongnam, KR
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Seongnam, KR
Modalities: Cell Therapy
Capacity assessment: 53.0/100

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Frequently Asked Questions About CHA Medical & Bio Group

What is CHA Medical & Bio Group's CDMO Signal Score?
CHA Medical & Bio Group has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating CHA Medical & Bio Group for a manufacturing program?
Use the free AI matchmaker to compare CHA Medical & Bio Group against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs →

Similar CDMOs

Green Cross Cell
Yongin, KR
Signal Score: 56.5
Cell Therapy
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 84.0
CAR-T, Cell Therapy
Takeda
Boston, MA · Zurich, CH
Signal Score: 83.4
AAV, Cell Therapy

Compare CHA Medical & Bio Group with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on CHA Medical & Bio Group
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.